The effects of methylene blue on lung injury in septic rats

Objective & Hypothesis:Aim: The aim of this study is to investigate the effects of methylene blue (MB) on NO production, antioxidant status and lipid peroxidation in lung injury during the different stages of sepsis in rats.

📊

Key Findings & Data:Material and methods:Sixty Sprague Dawley rats weighing 200-230 g, were randomly divided into 3 groups.

💡

Conclusion & Impact:Methylene blue, significantly decreased NOx and MDA levels in both early and late sepsis groups compared to group S (p

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Aim: The aim of this study is to investigate the effects of methylene blue (MB) on NO production, antioxidant status and lipid peroxidation in lung injury during the different stages of sepsis in rats. Material and methods:Sixty Sprague Dawley rats weighing 200-230 g, were randomly divided into 3 groups. The rats of the first group were sham operated (control, "group C); the second group, sepsis (group S); the third group received MB (25mg/kg, i.p.), MBS (sepsis+MB). Sepsis was induced by caecal ligation and puncture method. Each group was randomly subdivided into two subgroups (early and late sepsis) consisting of 10 rats which were sacrificed at 9 or 18 h after surgical procedure. In the lung tissue, total nitrite/nitrate (NOX), superoxide dismutase (SOD), catalyse (CAT), ğlutathion peroxidase (GSH-PX) and malondialdehyde (MDA) levels were measured. Damage to the lung tissue was graded by a pathologist on a scale of 1 (best) to 4 (worst). Results: In group MBS, CAT levels increased significantly both in early and late sepsis groups, whereas, SOD and GSH-PX levels increased significantly only in early sepsis groups compared to group S. Methylene blue, significantly decreased NOx and MDA levels in both early and late sepsis groups compared to group S (p

Özet

Amaç: Sepsisin farklı fazlarında, akciğer dokusundaki nitrik oksit (NO) üretimi, antioksidan kapasiteve lipid peroksidasyonu üzerine metilen mavisinin (MM) etkileri rat sepsis modelinde araştırıldı. Gereç ve Yöntem: 200-230 g, Sprague Dawley cinsi 60 rat rastgele 3 gruba (n=20) ayrıldı: 1. grup, kontrol grubu (grup K); 2. grup, sepsis (grup S); 3.grup, sepsis+MM 25mg/kg intraperitoneal (grup MMS). Sepsis, çekal ligasyon ve delme metodu ile oluşturuldu. Her grup rasgele 10 rattan oluşan iki alt gruba ayrıldı. Erken sepsis grubu cerrahi prosedürden 9 s, geç sepsis grubu 18 s sonra sakrifiye edildi. Akciğer dokusunda süperoksid dismutaz (SOD), katalaz (CAT), glutatyon peroksidaz (GSH-Px), malondialdehid (MDA) ve total nitrit+nitrat (N0x) düzeyleri ölçüldü. Akciğer doku kesitleri 1-4 arası doku hasar skorlamasına göre histopatolojik olarak değerlendirildi. Bulgular: Grup MMS'de, CAT düzeyi erken ve geç sepsis döneminde, SOD ve GSH-Px düzeyi ise sadece erken sepsis döneminde grup S'ye göre anlamlı olarak arttı. MM, hem erken hem de geç sepsis dönemlerinde NOx ve MDA düzeylerini grup S'ye göre anlamlı olarak azalttı (p

🔖

Cite This Article

BAYRAKTAR, N., KARAMAN, A., SIZANLI, E. E., DEMİRBİLEK, S., ERSOY, M. Ö., TÜRKMEN, E., KARADAĞ, N. (2022). The effects of methylene blue on lung injury in septic rats. İnönü Üniversitesi Tıp Fakültesi Dergisi, Cilt: 11 - Sayı: 4, 207–211. https://ajindex.com/articles/548846

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (15)

Lang JD, McArdle PJ, O'Reilly PJ, Matalon S. Oxidant-antioxidant balance in acute lung injury. Chest 2002; 122 (Suppl 6): 314-20
Ware LB. Advances in the pathogenesis and treatment of the acute respiratory distress syndrome. Clinical Pulmonary Med 2003; 10:208-18
Metnitz PGH, Battens C, Fischer M, Fridrich P, Steltzer H, Druml W. Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med 1999; 25: 180-5
Roth E, Manhart N, Wessner B. Assessing the antioxidative status in critically ill patients. Curr Opin Clin Nutr Metab Care 2004; 7:161-8
Safaris SC, Babbs CF, Voorhees WD. Methylene blue as an inhibitor of superoxide generation by xanthine oxidase: a potential new drug for the attenuation of ischemia/reperfusion injury. Biochem Pharmacol 1991; 42: 499-506
Weinbroum A, Goldin I, Kluge Y. Methylene blue in preventing hemodynamics and metabolic derangement following superior mesenteric artery clamping/unclamping: An intratracheal vs. intraperitoneal dose response study. Shock 2002; 17: 372-6
Donati A, Conti G, Loggi S, et al. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? Crit Care Med 2002; 30: 2271-7
Cheng X, Pang C. Pressor and vasoconstrictor effects of methylene blue in endotoxaemic rats. Arch Pharmacol 1998; 357: 648-53
Galili Y, Kluger Y, Mianski Z, Iaina A, Vollman Y, Marmur S, Soffer D, Chernikovsky T, Klausner JP, Rabau MY. Methylene Blue- a promising treatment modality in sepsis induced by bowel perforation. Eur Surg Res 1997; 29:390-5
Galili Y, Ben-Abraham R, Weinbroum A, Marmur S, Iaina A, Volman Y, Peer G, Szold O, Soffer D, Klausner J, Rabau M, Kluger Y. Methylene blue prevents pulmonary injury after intestinal ischemia-reperfusion. J Trauma 1998; 45:222-6
Kirov MY, Evgenov OV, Evgenov NV, Egorina EM, Sovershaev MA, Sveinbjornsson B, Nedashkovsky EV, Bjertnaes LJ. Infusion of methylene blue in human septic shock: A pilot, randomized, controlled study. Crit Care Med 2001; 29: 1860-7
Hwang TL, Yang JT, Lau YT. Arginine- nitric oxide pathwayin plasma membrane of rat hepatocytes during early and late sepsis. Crit Care Med 1999; 27: 137-41
Wichterman KA, Baue AE, Ch.audry IH. Sepsis and septic shock- a review of laboratory models and a proposal. J Surg Res 1980; 29:189-201
Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500
Paglia DE, Valent